Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Revenue

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹666 Cr₹560 Cr₹450 Cr₹484 Cr₹600 Cr

What is the latest Revenue of ORCHID PHARMA ?

The latest Revenue ratio of ORCHID PHARMA is ₹666 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹666 Cr
Mar2023₹560 Cr
Mar2022₹450 Cr
Mar2021₹484 Cr
Mar2020₹600 Cr

How is Revenue of ORCHID PHARMA Trending?

Years Revenue % Change
Mar2024 ₹666 Cr
19.00
Mar2023 ₹560 Cr
24.33
Mar2022 ₹450 Cr
-6.97
Mar2021 ₹484 Cr
-19.36
Mar2020 ₹600 Cr -

Compare Revenue of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,713.3 Cr 1.8% 7% -35.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

1.8%

7%

-35.5%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses